Beneficial effect of tetrandrine on refractory epilepsy via suppressing P-glycoprotein

References

• Lazarowski A, Czornyj L. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions. Drug Metabol Drug Interact 2011;26(1):21–6.
   PubMedGoogle Scholar
• Arts WF, Geerts AT. When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence. Eur J Paediatr Neurol 2009;13(2):93–101.
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Kerb R, Weale ME, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003;348(15):1442–8.
   PubMed Web of Science ®Google Scholar
• Loscher W, Langer O. Imaging of P-glycoprotein function and expression to elucidate mechanisms of pharmacoresistance in epilepsy. Curr Top Med Chem 2010;10(17):1785–91.
   PubMed Web of Science ®Google Scholar
• Robey RW, Lazarowski A, Bates SE. P-glycoprotein–a clinical target in drug-refractory epilepsy? Mol Pharmacol 2008;73(5):1343–6.
   PubMed Web of Science ®Google Scholar
• Seegers U, Potschka H, Loscher W. Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy. Epilepsy Res 2002;51(3):257–68.
   PubMed Web of Science ®Google Scholar
• Volk H, Potschka H, Loscher W. Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables. J Histochem Cytochem 2005;53(4):517–31.
   PubMed Web of Science ®Google Scholar
• van Vliet EA, van Schaik R, Edelbroek PM, et al. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats. J Pharmacol Exp Ther 2007;322(1):141–7.
   PubMed Web of Science ®Google Scholar
• Weiss J, Kerpen CJ, Lindenmaier H, et al. Interaction of antiepileptic drugs with human P-glycoprotein in vitro. J Pharmacol Exp Ther 2003;307(1):262–7.
   PubMed Web of Science ®Google Scholar
• Iannetti P, Parisi P, Spalice A, et al.. Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res 2009;85(1):89–95.
   PubMed Web of Science ®Google Scholar
• Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008;9(1): 105–27.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu J, Wang T, et al. The relaxation mechanisms of tetrandrine on the rabbit corpus cavernosum tissue in vitro. Nat Prod Res 2009;23(2):112–21.
   PubMed Web of Science ®Google Scholar
• Xie QM, Tang HF, Chen JQ, Bian RL. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin 2002;23(12):1107–13.
   PubMed Web of Science ®Google Scholar
• Wang G, Lemos JR, Iadecola C. Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 2004;25(3):120–3.
   PubMed Web of Science ®Google Scholar
• Chen YJ. Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin 2002;23(12):1102–6.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tseng SH. The potential of tetrandrine against gliomas. Anticancer Agents Med Chem 2010;10(7):534–42.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao Y, Wang C, et al.. Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells. Med Sci Monit 2012;18(10):BR383–8.
   PubMed Web of Science ®Google Scholar
• Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32(3):281–94.
   PubMedGoogle Scholar
• Hsu YC, Chiu YT, Lee CY, et al.. Anti-fibrotic effects of tetrandrine on bile-duct ligated rats. Can J Physiol Pharmacol 2006;84(10):967–76.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Ng LT. Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol Pharm Bull 2007;30(1):59–62.
   PubMed Web of Science ®Google Scholar
• Xu M, Sheng LH, Zhu XH, et al.. Reversal effect of Stephania tetrandra-containing Chinese herb formula SENL on multidrug resistance in lung cancer cell line SW1573/2R120. Am J Chin Med 2010;38(2):401–13.
   PubMed Web of Science ®Google Scholar
• Jin J, Wang FP, Wei H, Liu G. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromote- trandrine. Cancer Chemother Pharmacol 2005;55(2):179–88.
   PubMed Web of Science ®Google Scholar
• Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol 2010;46(3):308–16.
   PubMed Web of Science ®Google Scholar
• Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res 2006;68(3):213–28.
   PubMed Web of Science ®Google Scholar
• Zhang C, Kwan P, Zuo Z, Baum L. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. Life Sci 2010;86(23–24):899–905.
   PubMed Web of Science ®Google Scholar
• Li Y, Yuan H, Yang K, et al.. The structure and functions of P-glycoprotein. Curr Med Chem 2010;17(8):786–800.
   PubMed Web of Science ®Google Scholar
• Dai CL, Xiong HY, Tang LF, et al. Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice. Cancer Chemother Pharmacol 2007;60(5):741–50.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang K, Zhang G, et al.. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study. Planta Med 2010;76(1):53–61.
   PubMed Web of Science ®Google Scholar
• Olsen CM, Meussen-Elholm ET, Roste LS, Tauboll E. Antiepileptic drugs inhibit cell growth in the human breast cancer cell line MCF7. Molecular and cellular endocrinology 2004;213(2):173–9.
   PubMed Web of Science ®Google Scholar
• Cinatl J, Jr., Cinatl J, Driever PH, et al. Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs 1997;8(10):958–63.
   PubMed Web of Science ®Google Scholar
• Machado MC, Bellodi-Privato M, Kubrusly MS, et al. Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo. Journal of experimental therapeutics & oncology 2011;9(2):85–92.
   PubMedGoogle Scholar
• Ju S, Greenberg ML. Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis. Molecular microbiology 2003;49(6):1595–603.
   PubMed Web of Science ®Google Scholar
• Rocchi P, Tonelli R, Camerin C, et al. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Oncol Rep 2005;13(6):1139–44.
   PubMed Web of Science ®Google Scholar
• Umka J, Mustafa S, ElBeltagy M, et al. Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 2010;166(1):15–22.
   PubMed Web of Science ®Google Scholar
• Gibbs JP, Adeyeye MC, Yang Z, Shen DD. Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport. Epilepsy Res 2004;58(1):53–66.
   PubMed Web of Science ®Google Scholar
• Shen H, Xu W, Chen Q, Wu Z, et al.. Te prevents acquired drug resistance trandrineof K562 cells through inhibition of mdr1 gene transcription. J Cancer Res Clin Oncol 2010;136(5):659–65.
   PubMed Web of Science ®Google Scholar
• Xue Y, Wang Y, Feng DC, et al.. Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-kappaB pathway. Acta Pharmacol Sin 2008;29(2):245–51.
   PubMed Web of Science ®Google Scholar
• He FQ, Qiu BY, Zhang XH, et al. Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-kappaB activation in a rat model of Alzheimer's disease induced by amyloid-beta(1-42). Brain Res 2011;1384:89–96.
   PubMed Web of Science ®Google Scholar
• Wu CJ, Wang YH, Lin CJ, et al.. Tetrandrine down-regulates ERK/NF-kappaB signaling and inhibits activation of mesangial cells. Toxicol In Vitro 2011;25(8):1834–40.
   PubMed Web of Science ®Google Scholar